Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2011-12-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastrointestinal Tolerability Following Multiple Servings of a Novel Dietary Fiber
NCT02532985
Acute Gastrointestinal Tolerability Following a Single Serving of a Novel Dietary Fiber
NCT02530762
Effects of Dietary Fibre in Irritable Bowel Syndrome (IBS)
NCT03803319
Fibre and Gas in Irritable Bowel Syndrome
NCT03265002
The Effect of Gluten in Patients With Irritable Bowel Syndrome and Healthy Volunteers
NCT03869359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dietary Fiber - Dose 1
Dietary fiber will be added to study foods
Dietary fiber
A proprietary fiber will be given to subjects
Dietary Fiber - Dose 2
Dietary fiber will be added to study foods
Dietary fiber
A proprietary fiber will be given to subjects
Control
Study foods with no added fiber will be given
Dietary fiber
A proprietary fiber will be given to subjects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary fiber
A proprietary fiber will be given to subjects
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 - 54 years
* BMI \< 30 kg/m2
Exclusion Criteria
* recent use of antibiotics
* very high fiber intake
* use of medications known to affect GI function
* presence of allergies to study foods
18 Years
54 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ingredion Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin Maki, PhD
Role: PRINCIPAL_INVESTIGATOR
Provident Clinical Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Provident Clinical Research and Consulting Inc
Glen Ellyn, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.